Suppr超能文献

验证简短国际多发性硬化认知评估(BICAMS)在墨西哥多发性硬化症患者中的应用。

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in individuals with multiple sclerosis from Mexico.

机构信息

Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, Jalisco, México.

Departamento de Neurociencias, Universidad de California San Diego, La Jolla, California, USA.

出版信息

Mult Scler Relat Disord. 2024 Mar;83:105451. doi: 10.1016/j.msard.2024.105451. Epub 2024 Jan 17.

Abstract

BACKGROUND

Cognitive impairment is observed in 43-70 % of Multiple sclerosis (MS) patients. One of the most widely used batteries for cognitive assessment in this population is the Brief International Cognitive Assessment for MS (BICAMS). The objective of this study was to validate and assess the reliability of the BICAMS in a Mexican population with MS and to obtain and provide regression-based norms.

METHODS

One hundred healthy controls (HCs) and 100 patients with multiple sclerosis participated in the present study, and groups were matched for age, years of education and sex. Subjects completed all three tests of the BICAMS. Test-retest measures were obtained from 30 patients to test reliability.

RESULTS

The sample´s average age was 43.39 ± 6.03 years old, and the average years of education was 12.55 ± 2.52 years. Approximately 63 % of the participants were female. The groups did not differ in age, years of education, or sex. The MS group performed significantly worse than the HCs group on all three neuropsychological tests. A significant difference was observed for the SDMT (t = 10.166; p=<0.001), CVLT-II (t = 10.949; p=<0.001), and BVMT-R (t = 2.636; p = 0.009). For all comparisons, the effect size (d) for each test was calculated as follows: SDMT= 0.58 and CVLT-II= 0.61. The test-retest coefficients for each test were as follows: SDMT: r = 0.95; CVLT-II: r = 0.84; and BVMT-R = 0.81.

CONCLUSION

The BICAMS can provide information on cognitive impairment in MS patients, and this information can be used by neuropsychologists for cognitive rehabilitation in different domains.

摘要

背景

认知障碍在 43-70%多发性硬化症(MS)患者中观察到。在该人群中,最广泛用于认知评估的电池之一是简短国际多发性硬化症认知评估(BICAMS)。本研究的目的是验证和评估 BICAMS 在墨西哥多发性硬化症患者中的可靠性,并获得和提供基于回归的规范。

方法

本研究纳入 100 名健康对照者(HCs)和 100 名多发性硬化症患者,两组在年龄、受教育年限和性别上相匹配。受试者完成了 BICAMS 的所有三项测试。从 30 名患者中获得测试-重测测量值以测试可靠性。

结果

样本的平均年龄为 43.39 ± 6.03 岁,平均受教育年限为 12.55 ± 2.52 年。大约 63%的参与者为女性。两组在年龄、受教育年限或性别上没有差异。MS 组在所有三项神经心理学测试中的表现均明显差于 HCs 组。在 SDMT(t=10.166;p<0.001)、CVLT-II(t=10.949;p<0.001)和 BVMT-R(t=2.636;p=0.009)上,两组间均有显著差异。对于所有比较,计算了每个测试的效应大小(d),如下所示:SDMT=0.58 和 CVLT-II=0.61。每个测试的测试-重测系数如下:SDMT:r=0.95;CVLT-II:r=0.84;BVMT-R:r=0.81。

结论

BICAMS 可以提供多发性硬化症患者认知障碍的信息,神经心理学家可以在不同领域将这些信息用于认知康复。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验